Resultados de la búsqueda 231-240 of 9171 for Drug-resistant TB
... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This study is researching an experimental drug called linvoseltamab in combination with ...
... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...
Treatment Resistant Depression Subcallosal Cingulate Network. Rochester, Minn. The purpose of this study is to evaluate the effectiveness and safety of ...
... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase ... Currently, most drug-related cancer care is conducted in clinic type ...
This study is designed to assess the degree to which high-frequency spinal cord stimulation may help with pain after brachial plexus avulsion injury. A Study Of ...
... resistant). Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an ...
PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study Of ...
The purpose of this study is to compare two types of surgery for the treatment ... Treatment Resistant Depression Subcallosal Cingulate Network. Rochester, Minn ...
The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid hemorrhage (aSAH)- ...
A Study to Evaluate Ultrasound Microvessel Imaging. Rochester, Minn. The purpose of this study is to find out the optimal acquisition parameters for ultrasound ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?